Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.68 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL10432863 | 0.98 | HPGD (0.66) | HPGDMEN1KMT2AHSD17B10HCAR3 | |
| Hydrochloric Acid SCHEMBL9787788 | 0.98 | HPGD (0.66) | HPGDMEN1KMT2AHSD17B10HCAR3 | |
| SCHEMBL2146965 | 0.88 | MEN1 (0.68) | HPGDMEN1KMT2AHSD17B10HCAR3 | |
| SCHEMBL4233005 | 0.86 | MEN1 (0.66) | HPGDMEN1KMT2AHSD17B10RAB9A | |
| SCHEMBL24942737 | 0.84 | MEN1 (0.64) | HPGDMEN1KMT2AHSD17B10RAB9A | |
| SCHEMBL250816 | 0.84 | MEN1 (0.64) | HPGDMEN1KMT2AHSD17B10HCAR3 | |
| SCHEMBL630931 | 0.84 | MEN1 (0.64) | HPGDMEN1KMT2AHSD17B10SMN1; SMN2 | |
| SCHEMBL9675201 | 0.84 | MEN1 (0.64) | HPGDMEN1KMT2AHSD17B10SMN1; SMN2 | |
| SCHEMBL14638103 | 0.84 | MEN1 (0.64) | HPGDMEN1KMT2AHSD17B10HCAR3 | |
| SCHEMBL9674221 | 0.81 | KMT2A (0.60) | HPGDMEN1KMT2AHSD17B10RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116606290-A | Method for efficiently catalyzing and synthesizing fluorine-containing polypeptide condensing agent by adopting green acid binding agent | 浙江大学 | 2023-08-18 | — | — | CN | claimed |
| CN-116075510-A | 1H-benzo [ d ] imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis | 百时美施贵宝公司 | 2023-05-05 | — | — | CN | claimed |
| EP-0274226-B1 | PROCESS FOR THE PRODUCTION OF GLYCEROL FROM FORMALDEHYDE | BP Chemicals Limited (GB) | 1991-03-13 | — | — | EP | claimed |
| WO-2026107422-A1 | 6-(PYRIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260078114-A1 | COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOF | TYK MEDICINES INC (CN) | 2026-03-19 | — | — | US | disclosed |
| US-20260015339-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | UNIVERSITE GRENOBLE ALPES (FR) | 2026-01-15 | — | — | US | disclosed |
| EP-4655285-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | Université Grenoble Alpes (FR) | 2025-12-03 | — | — | EP | disclosed |
| US-12378232-B2 | Cyclin dependent kinase inhibitors | PFIZER INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250122174-A1 | Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using Same | SHENZHEN YUANLI SHENWAN INNOVATIVE MEDICINE CO LTD (CN) | 2025-04-17 | — | — | US | disclosed |
| WO-2024156819-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | UNIVERSITE GRENOBLE ALPES (FR) | 2024-08-02 | — | — | WO | disclosed |
| EP-4406939-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | Université Grenoble Alpes (FR) | 2024-07-31 | — | — | EP | disclosed |
| US-5017579-A | Use of aminoalkoxyphenyl derivatives for reducing and/or controlling excessive intraocular pressure | SANOFI (FR) | 1991-05-21 | — | — | US | disclosed |
| US-4994474-A | Hypotensive agents | SANOFI (FR) | 1991-02-19 | — | — | US | disclosed |
| EP-0398358-A2 | Aluminum electroplating method | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1990-11-22 | — | — | EP | disclosed |
| US-4957925-A | HYPOTENSIVE AGENTS, ANTIARRHYTHMIA AGENTS, TREATMENT OF ANGINA | SANOFI (FR) | 1990-09-18 | — | — | US | disclosed |
| EP-0302793-A2 | Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same | ELF SANOFI (FR) | 1989-02-08 | — | — | EP | disclosed |
| US-4620871-A | SALTS OF PHTHALAZINES AND BENZIMIDAZOLES | ESZAKMAGYARORSZAGIVEGYIMUVEK (HU) | 1986-11-04 | — | — | US | disclosed |
| US-4460709-A | Process for producing oxygen-containing organic compounds | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1984-07-17 | — | — | US | disclosed |
| US-4160829-A | ANTIBIOTICS | GIST-BROCADES N.V. (NL) | 1979-07-10 | — | — | US | disclosed |
| US-4151280-A | ANTIALLERGENS | ROUSSEL UCLAF (FR) | 1979-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015339-A1 | CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY | CBR1, CYP4X1, CBR3 | HPGD 2789/4885MEN1 4555/4885KMT2A 3594/4885 |
| US-20260078114-A1 | COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOF | CDK4, CDK1, CDK3 | HPGD 1875/4885MEN1 2188/4885KMT2A 1465/4885 |
| US-12378232-B2 | Cyclin dependent kinase inhibitors | CCNY, CCNI, CCNK | HPGD 2192/4885MEN1 1447/4885KMT2A 758/4885 |
| US-20250122174-A1 | Heteroaryl Compounds As HPK1 Inhibitors And Methods Of Using Same | SGK1, HYPK, PCK1 | HPGD 418/4885MEN1 2249/4885KMT2A 2422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.